Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway

Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway

The astrocytic cystine/glutamate antiporter system xc– (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, redox b...

Full description

Bibliographic Details
Main Authors:	Eduard Bentea, Laura De Pauw, Lise Verbruggen, Lila C. Winfrey, Lauren Deneyer, Cynthia Moore, Giulia Albertini, Hideyo Sato, Ann Van Eeckhaut, Charles K. Meshul, Ann Massie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	glutamate neuroprotection aging proteasome inhibition Parkinson’s disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2021.796635/full

Similar Items

Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
by: Natalie R.S. Goldberg, et al.
Published: (2012-03-01)

Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
by: Tianhong Pan, et al.
Published: (2008-10-01)

Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway
by: Lei eLiu, et al.
Published: (2014-08-01)

Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
by: F. L'Episcopo, et al.
Published: (2011-02-01)

Reactivity of 4-tert-Butyldimethylsiloxy-1,2,3,6-tetrahydropyridines with Hydrazines
by: Manuel Medarde, et al.
Published: (2006-11-01)

Synthesis of new analogs of N-substituted(benzoylamino)-1,2,3,6-tetrahydropyridines
by: Gedeon Shasline, et al.
Published: (2024-04-01)

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
by: Impagnatiello Francesco, et al.
Published: (2010-11-01)

Isopropyl 1-benzoyl-4-benzoyloxy-2,6-diphenyl-1,2,3,6-tetrahydropyridine-3-carboxylate
by: E. Govindan, et al.
Published: (2014-08-01)

An efficient synthesis of lactacystin beta-lactone.
by: Donohoe, T, et al.
Published: (2004)

Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.
by: Aziz, T, et al.
Published: (1992)

Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
by: Minjuan Bian, et al.
Published: (2012-01-01)

Neuronal regeneration in the goldfish telencephalon following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) insult
by: Maddie J. Venables, et al.
Published: (2018-03-01)

Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
by: Ting Yan, et al.
Published: (2014-01-01)

Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
by: Aziz, T, et al.
Published: (1991)

Neuroprotective potential of quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
by: Shamsher Singh, et al.
Published: (2017-01-01)

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences
by: Giulia Costa, et al.
Published: (2021-08-01)

Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model
by: Zijuan Zhang, et al.
Published: (2022-03-01)

Korean Red Ginseng Enhances Neurogenesis in the Subventricular Zone of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice
by: Sun Ryu, et al.
Published: (2018-11-01)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
by: Kristina Repova, et al.
Published: (2022-09-01)

DIFFERENTIALLY EXPRESSED GENES AND THEIR SIGNIFICANCE THE SUBSTANTIA NIGRA OF MICE WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSON’S DISEASE
by: LI Beining, YAO Zhengyang, JIAO Qian, CHEN Xi, JIANG Hong, DU Xixun
Published: (2023-04-01)

Nrf2 signaling contributes to the neuroprotective effect of Cicadidae Periostracum against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
by: Hye-Sun Lim, et al.
Published: (2022-03-01)

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury
by: Marta G. Vučković, et al.
Published: (2008-11-01)

Effect of treadmill exercise on catalepsy and the expression of the BDNF gene in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine male NMRI mice
by: Neda Nikokalam Nazif, et al.
Published: (2020-04-01)

Dispersed activity during passive movement in the globus pallidus of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primate.
by: Yaara Erez, et al.
Published: (2011-01-01)

Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein
by: Eduard eBentea, et al.
Published: (2015-03-01)

The proteasome and the degradation of oxidized proteins: Part I—structure of proteasomes
by: Tobias Jung, et al.
Published: (2013-01-01)

Unraveling the central proopiomelanocortin neural circuits
by: Aaron J. Mercer, et al.
Published: (2013-02-01)

<i>Ganoderma lucidum</i> Modulates Inflammatory Responses following 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice
by: Zhili Ren, et al.
Published: (2022-09-01)

Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
by: Kyota Fujita, et al.
Published: (2009-09-01)

Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease
by: Ken-ichi Kinoshita, et al.
Published: (2017-05-01)

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
by: Fedor Simko, et al.
Published: (2017-07-01)

Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson’s disease
by: Hye-Sun Lim, et al.
Published: (2024-01-01)

Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice
by: Javad Hami, et al.
Published: (2016-01-01)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
by: Camille Schlesser, et al.
Published: (2022-05-01)

Proteomic profiling reveals the potential mechanisms and regulatory targets of sirtuin 4 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s mouse model
by: Huidan Weng, et al.
Published: (2023-01-01)

Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study.
by: Khairiah Razali, et al.
Published: (2022-01-01)

Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study
by: Khairiah Razali, et al.
Published: (2022-01-01)

Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
by: Jong Hee Choi, et al.
Published: (2018-05-01)

Normal Proteasome Function Is Needed to Prevent Kidney Graft Injury during Cold Storage Followed by Transplantation
by: Dinesh Bhattarai, et al.
Published: (2024-02-01)

Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson’s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model
by: Élise Pépin, et al.
Published: (2020-02-01)